Diane Stephenson, Ramona Belfiore-Oshan, Yashmin Karten, Jessi Keavney, D. Kevin Kwok, Terina Martinez, Joe Montminy, Martijn L. T. M. Müller, Klaus Romero & Sudhir Sivakumaran
Neurological disorders represent some of the most challenging therapeutic areas for successful drug approvals. The escalating global burden of death and disability for such diseases represents a significant worldwide public health challenge, and the rate of failure of new therapies for chronic progressive disorders of the nervous system is higher relative to other non-neurological conditions. Click here to read the manuscript in its entirety.
